rs374748006

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001099922.3(ALG13):​c.638G>A​(p.Ser213Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000076 in 1,210,094 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 26 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., 12 hem., cov: 23)
Exomes 𝑓: 0.000042 ( 0 hom. 14 hem. )

Consequence

ALG13
NM_001099922.3 missense

Scores

3
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 4.83

Publications

1 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13-AS1 (HGNC:41277): (ALG13 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013918281).
BP6
Variant X-111708281-G-A is Benign according to our data. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-111708281-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 381446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000411 (46/112019) while in subpopulation AMR AF = 0.00398 (42/10562). AF 95% confidence interval is 0.00302. There are 0 homozygotes in GnomAd4. There are 12 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 12 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG13NM_001099922.3 linkc.638G>A p.Ser213Asn missense_variant Exon 4 of 27 ENST00000394780.8 NP_001093392.1 Q9NP73-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG13ENST00000394780.8 linkc.638G>A p.Ser213Asn missense_variant Exon 4 of 27 2 NM_001099922.3 ENSP00000378260.3 Q9NP73-1

Frequencies

GnomAD3 genomes
AF:
0.000411
AC:
46
AN:
111964
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00398
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00133
GnomAD2 exomes
AF:
0.0000558
AC:
10
AN:
179278
AF XY:
0.0000597
show subpopulations
Gnomad AFR exome
AF:
0.0000810
Gnomad AMR exome
AF:
0.000110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000253
Gnomad OTH exome
AF:
0.000899
GnomAD4 exome
AF:
0.0000419
AC:
46
AN:
1098075
Hom.:
0
Cov.:
31
AF XY:
0.0000385
AC XY:
14
AN XY:
363501
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26402
American (AMR)
AF:
0.000483
AC:
17
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54147
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40517
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.0000131
AC:
11
AN:
841996
Other (OTH)
AF:
0.000369
AC:
17
AN:
46081
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000411
AC:
46
AN:
112019
Hom.:
0
Cov.:
23
AF XY:
0.000351
AC XY:
12
AN XY:
34203
show subpopulations
African (AFR)
AF:
0.0000649
AC:
2
AN:
30803
American (AMR)
AF:
0.00398
AC:
42
AN:
10562
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2656
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3574
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2678
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6090
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53233
Other (OTH)
AF:
0.00131
AC:
2
AN:
1522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000375
Hom.:
4
Bravo
AF:
0.00107
ESP6500AA
AF:
0.000381
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000831
AC:
10

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 36 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 17, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Inborn genetic diseases Benign:1
Sep 14, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ALG13-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T;.;.;.;.
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.69
T;T;.;T;.
MetaRNN
Benign
0.014
T;T;T;T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
0.34
N;.;.;.;.
PhyloP100
4.8
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.63
N;.;N;.;.
REVEL
Benign
0.080
Sift
Benign
0.14
T;.;T;.;.
Sift4G
Uncertain
0.0030
D;D;D;D;D
Polyphen
0.20
B;B;B;B;B
Vest4
0.13
MVP
0.50
MPC
0.17
ClinPred
0.013
T
GERP RS
5.7
Varity_R
0.087
gMVP
0.12
Mutation Taster
=99/1
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374748006; hg19: chrX-110951509; API